|
ADPRH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95260038640777E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.38178357644847E-12 |
| Normal-vs-Stage2 |
1.439640E-03 |
| Normal-vs-Stage3 |
1.59509999997365E-06 |
| Normal-vs-Stage4 |
1.664280E-02 |
| Stage1-vs-Stage2 |
1.280000E-01 |
| Stage1-vs-Stage3 |
4.043700E-02 |
| Stage1-vs-Stage4 |
1.169340E-04 |
| Stage2-vs-Stage3 |
9.407800E-01 |
| Stage2-vs-Stage4 |
1.640210E-01 |
| Stage3-vs-Stage4 |
4.260000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6316004103345E-10 |
| Normal-vs-AfricanAmerican |
3.779300E-03 |
| Normal-vs-Asian |
1.903560E-01 |
| Caucasian-vs-AfricanAmerican |
2.499200E-01 |
| Caucasian-vs-Asian |
8.429800E-01 |
| AfricanAmerican-vs-Asian |
5.434200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.72120001479459E-09 |
| Normal-vs-Female |
9.34819999187653E-10 |
| Male-vs-Female |
4.207600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.026060E-04 |
| Normal-vs-Age(41-60Yrs) |
2.84629986246898E-10 |
| Normal-vs-Age(61-80Yrs) |
4.70550000075676E-08 |
| Normal-vs-Age(81-100Yrs) |
1.009050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.875210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.847800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.213690E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.272790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.704300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.402010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.86889999990115E-07 |
| Normal-vs-Grade 2 |
1.14686038443779E-13 |
| Normal-vs-Grade 3 |
3.48480000000873E-06 |
| Normal-vs-Grade 4 |
1.250460E-02 |
| Grade 1-vs-Grade 2 |
2.625200E-01 |
| Grade 1-vs-Grade 3 |
6.599200E-03 |
| Grade 1-vs-Grade 4 |
6.598400E-03 |
| Grade 2-vs-Grade 3 |
1.025290E-04 |
| Grade 2-vs-Grade 4 |
1.624830E-04 |
| Grade 3-vs-Grade 4 |
1.964040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.6876500197327E-12 |
| Normal-vs-ccB subtype |
1.88840000003854E-06 |
| ccA subtype-vs-ccB subtype |
1.236910E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06219999462809E-08 |
| Normal-vs-N1 |
1.011580E-01 |
| N0-vs-N1 |
5.657200E-01 |
|
|
